12-Jun-2026
Globe Newswire (Thu, 28-May 9:04 AM ET)
Progyny, Inc. Announces Share Repurchase Program
Globe Newswire (Tue, 26-May 8:00 AM ET)
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference
Globe Newswire (Mon, 11-May 10:57 AM ET)
Progyny Delivers Strong Q1 2026: Gross Margin Hits Multiyear High Despite Large Client Exit
Market Chameleon (Fri, 8-May 5:45 AM ET)
Progyny, Inc. Announces First Quarter 2026 Results
Globe Newswire (Thu, 7-May 4:01 PM ET)
Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
Globe Newswire (Thu, 23-Apr 1:55 PM ET)
Globe Newswire (Thu, 16-Apr 9:05 AM ET)
Progyny Commemorates 10 Years of Redefining Women's Health and Family Building Care
Globe Newswire (Wed, 1-Apr 9:23 AM ET)
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Progyny trades on the NASDAQ stock market under the symbol PGNY.
As of June 12, 2026, PGNY stock price climbed to $26.63 with 1,210,123 million shares trading.
PGNY has a beta of 0.57, meaning it tends to be less sensitive to market movements. PGNY has a correlation of 0.02 to the broad based SPY ETF.
PGNY has a market cap of $2.09 billion. This is considered a Mid Cap stock.
Last quarter Progyny reported $329 million in Revenue and $.50 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.11.
In the last 3 years, PGNY traded as high as $44.95 and as low as $13.39.
The top ETF exchange traded funds that PGNY belongs to (by Net Assets): IJR, VTI, IWM, VB, SPSM.
PGNY has underperformed the market in the last year with a return of +23.6%, while SPY returned +24.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PGNY shares. However, PGNY has outperformed the market in the last 3 month and 2 week periods, returning +52.2% and +4.2%, while SPY returned +11.6% and -1.9%, respectively. This indicates PGNY has been having a stronger performance recently.
PGNY support price is $25.03 and resistance is $26.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PGNY shares will trade within this expected range on the day.